Prestige Consumer Healthcare Inc.

Total Valuation

Prestige Consumer Healthcare Inc. carries a market capitalization of 2.21B, placing it among publicly traded companies globally. Its enterprise value stands at 4.22B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Prestige Consumer Healthcare Inc. currently has 47.37M shares outstanding.

Valuation Ratios

Prestige Consumer Healthcare Inc. trades at a trailing price-to-earnings ratio of 13.18. The price-to-sales ratio is 2.05, and the price-to-book ratio stands at 1.17.

Enterprise Valuation

On an enterprise value basis, Prestige Consumer Healthcare Inc. trades at an EV/EBITDA multiple of 13.08 and an EV/FCF ratio of 14.19. The EV/Sales ratio of 3.82 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 14.53 provides insight into valuation relative to core operating earnings.

Financial Position

Prestige Consumer Healthcare Inc. maintains a current ratio of 3.23, meaning it holds 3.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 107.86, indicating elevated leverage, while an interest coverage ratio of 7.00 demonstrates adequate ability to service its debt obligations.

Financial Efficiency

Prestige Consumer Healthcare Inc. posts a return on equity of 9.12 and a return on invested capital of 6.21.

Taxes

Over the trailing twelve months, Prestige Consumer Healthcare Inc. has paid 62.25M in income taxes, reflecting an effective tax rate of 26.57.

Stock Price Statistics

Prestige Consumer Healthcare Inc.'s stock has declined approximately -25.68559% over the past 52 weeks. The 50-day moving average sits at 50.34, while the 200-day moving average is 55.99.

Income Statement

Over the trailing twelve months, Prestige Consumer Healthcare Inc. generated 1.10B in revenue and converted that into 172.01M in net income, yielding earnings per share of 3.57. EBITDA reached 322.53M, while operating income came in at 290.17M.

Balance Sheet

Prestige Consumer Healthcare Inc. holds 89.13M in cash and equivalents against 2.07B in total debt, resulting in a net debt position of 1.93B. Total book value stands at 1.92B, with working capital of 343.01M providing operational flexibility.

Cash Flow

Prestige Consumer Healthcare Inc. produced 249.40M in operating cash flow over the past twelve months. After subtracting -14.04M in capital expenditures, free cash flow totaled 235.36M - equivalent to 4.91 per share.

Margins

Prestige Consumer Healthcare Inc. operates with a gross margin of 53.53, reflecting its pricing power and cost economics. The operating margin of 26.26 and net profit margin of 15.57 provide insight into operational efficiency.

Dividends & Yields

Scores

Prestige Consumer Healthcare Inc. posts an Altman Z-Score of 7.86, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.